Compare BEAM & HOG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BEAM | HOG |
|---|---|---|
| Founded | 2017 | 1903 |
| Country | United States | United States |
| Employees | N/A | 6400 |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Motor Vehicles |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.6B | 2.9B |
| IPO Year | 2019 | 1994 |
| Metric | BEAM | HOG |
|---|---|---|
| Price | $29.63 | $28.36 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 12 | 7 |
| Target Price | ★ $50.75 | $24.00 |
| AVG Volume (30 Days) | ★ 1.5M | 1.2M |
| Earning Date | 05-06-2026 | 05-05-2026 |
| Dividend Yield | N/A | ★ 3.05% |
| EPS Growth | ★ 82.31 | N/A |
| EPS | N/A | ★ 0.97 |
| Revenue | $24,000.00 | ★ $4,473,175,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $33.77 | $3.79 |
| P/E Ratio | ★ N/A | $28.19 |
| Revenue Growth | ★ 33.33 | N/A |
| 52 Week Low | $19.36 | $17.09 |
| 52 Week High | $38.26 | $31.25 |
| Indicator | BEAM | HOG |
|---|---|---|
| Relative Strength Index (RSI) | 51.16 | 52.01 |
| Support Level | $28.40 | $24.09 |
| Resistance Level | $31.98 | $28.71 |
| Average True Range (ATR) | 1.49 | 0.82 |
| MACD | 0.14 | -0.08 |
| Stochastic Oscillator | 54.56 | 29.76 |
Beam Therapeutics Inc is a biotechnology company committed to creating a new class of precision genetic medicines based on its proprietary base editing technology, with a vision of providing lifelong cures to patients suffering from serious diseases. The company is focused on its programs in the hematology and genetic disease portfolios, which comprise different product candidates in its pipeline, such as BEAM-101, which is being developed to target Sickle Cell Disease, BEAM-302, a liver-targeting lipid nanoparticle, being developed to target Alpha-1 antitrypsin deficiency, and other drug candidates including BEAM-302, BEAM-103 & 104. The company operates and manages its business in one operating segment, United States.
Harley-Davidson is a leading global manufacturer of heavyweight motorcycles across the custom, cruising, and touring categories, as well as related merchandise, parts, and accessories. In recent years, the firm has expanded into the adventure touring market with its Pan America model, into electric with the LiveWire brand, and is returning to smaller-displacement bikes with the Sprint. Its captive finance arm, Harley-Davidson Financial Services, provides wholesale financing to dealers and retail financing and insurance brokerage services to customers. Harley captured around 34% of the heavyweight domestic market in 2025.